The novel approach of the medication represents a major advance in the handling of the condition. Unlike existing drugs, tirzepatide affects two pathways – GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) https://tirzepatide-peptide505834.blogofchange.com/42687121/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment